Showing 521-530 of 7271 results for "".
DERM2020 Attendee Reaction: TJ Chao, MPAS, PA-C
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-attendee-reaction-tj-chao-mpas-pa-c/19846/TJ Chao, MPAS, PA-C from Atlanta, GA shares his thoughts on participating in DERM2020.Advances in Understanding the Skin’s Microbiome
https://practicaldermatology.com/series/dermatology-dispatches/advances-in-understanding-the-skins-microbiome/19772/A growing body of evidence suggests that cutaneous dysbiosis plays a role in atopic dermatitis, psoriasis, acne, and rosacea, explains Adam Friedman, MD. Efforts to encourage diversity in the skin’s microbiome with pre- and probiotics may change the way dermatologists treat these diseases in the futGene Expression Profile Testing in the Management of Malignant Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/gene-expression-profile-testing-in-the-management-ofmalignant-melanoma/23030/A test analyzes 31 specific genes in excised tumors to predict risk for metastasis.Perspective: The ABD's Push for Subspecialty Certification in Mohs Surgery Will Fracture Dermatology
https://practicaldermatology.com/topics/skin-cancer-photoprotection/perspective-the-abds-push-for-subspecialty-certification-in-mohs-surgery-will-fracture-dermatology/20502/Will SC infringe on the rights of non-certified dermatologists to preform Mohs? Could it lead to reduced exposure to this and other surgical treatments for future dermatologists in training?Physician Spotlight: Desiree Ratner, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-desiree-ratner-md/20505/Winning the war on non-melanoma skin cancer.Physician Spotlight: J. Matthew Knight, MD, FAAD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-j-matthew-knight-md-faad/20561/Dermatologists must act now to extinguish burnout or risk dire consequences.Panel Supports ATX-101; Melanoma Metastasis Test
https://practicaldermatology.com/topics/practice-management/dermwiretv-panel-supports-atx-101-melanoma-metastasis-test/18959/An FDA Advisory Panel Backs Kythera's ATX-101 for (Submental Fullness) or Double Chin, and a new genetic analysis may enhance SLN Biopsy findings to identify melanoma metastasis.Plus, Dan Siegel, MD, Darrell Rigel, MD, and Neal Bhatia, MD discuss the AAD's proposed dues increase and @NewDermMD launcThe Growing Importance of Social Media for Dermatologists
https://practicaldermatology.com/topics/practice-management/the-growing-importance-of-social-media-for-dermatologists/21591/Dermatology practitioners must realize that social media is not just a tool for building relationships; it is also good for their businesses.Diverse by Design: The Unique Molecular Footprints of IL-23 Biologics in Psoriasis
https://practicaldermatology.com/issues/april-2024/il23_biologics_in_psoriasis/24457/Christopher Bunick, MD, PhD, discusses a study that explores the structural basis of IL-23 targeted biologic therapies for psoriasis. By mapping the binding sites of these therapies on the IL-23 molecule and correlating molecular properties with clinical efficacy, the study offers insights into whyThe Digital Dermatologist: Why Physicians Should Embrace Coding Skills in the Modern Era
https://practicaldermatology.com/topics/practice-management/the-digital-dermatologist-why-physicians-should-embrace-coding-skills-in-the-modern-era/24034/A changing digital landscape means practitioners need to keep their digital toolkits up to date.